tiprankstipranks
Trending News
More News >

Kevin T Crofton Insider Profile

4 Followers
Kevin T Crofton, Director at Creo Medical, holds 5.45M shares in Creo Medical (Ticker: GB:CREO), holds 2.20M shares in DC Two Ltd. (Ticker: AU:AI1). Most recently, Kevin T Crofton Bought ― shares of Creo Medical on Jun 02, 2025 for an estimated value of 110.53K.
tipranks
Kevin T Crofton

Kevin T Crofton
Creo Medical (CREO)
Director

Ranked #28,671 out of 102,674 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+8.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

AU$2M
82.42%
17.58%
A breakdown of Kevin T Crofton's holdings

Insider Roles

Creo Medical
(CREO)
Director
DC Two Ltd.
(AI1)
Director
Roles that Kevin T Crofton holds in companies

Most Profitable Insider Trade

Stock:
DC Two Ltd.
(AI1)
Rating:Informative Buy
Date:Apr 04, 2025 - Today
Return:+74.40%
The most profitable trade made by Kevin T Crofton

Kevin T Crofton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Creo Medical
Jun 02, 2025
Director
Informative Buy
110.53K
£721.78K
DC Two Ltd.
May 19, 2025
Director
Informative Buy
76.00K
AU$154.00K
List of latest transactions for each holding click on a transaction to see Kevin T Crofton's performance on stock

Kevin T Crofton insider profile FAQ

What is the percentage of profitable transactions made by Kevin T Crofton?
The percentage of profitable transactions made by Kevin T Crofton is 40%.
    What is the average return per transaction made by Kevin T Crofton?
    The average return per transaction made by Kevin T Crofton is 8.60%.
      What stocks does Kevin T Crofton hold?
      Kevin T Crofton holds: GB:CREO, AU:AI1 stocks.
        What was Kevin T Crofton’s latest transaction?
        Kevin T Crofton latest transaction was an Informative Buy of 110.53K.
          What was Kevin T Crofton's most profitable transaction?
          Kevin T Crofton’s most profitable transaction was an Informative Buy of AU:AI1 stock on April 4, 2025. The return on the trade was 74.40%.
            What is Kevin T Crofton's role in Creo Medical?
            Kevin T Crofton's role in Creo Medical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.